ELTP

ELITE PHARMS INC by Elite Pharmaceuticals, Inc. (ELTP)

About ELITE PHARMS INC by Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals, Inc. engages in the provision of development and manufacture of pharmacological abuse-deterrent opioid products. It operates through the Abbreviated New Drug Applications and New Drug Applications segments. The ANDA segment includes generic pharmaceuticals. The NDA segment is composed of branded pharmaceuticals. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ.

Details

Daily high

$0.43

Daily low

$0.40

Price at open

$0.42

52 Week High

$0.75

52 Week Low

$0.12

Market cap

448.7M

Dividend yield

0.00%

Volume

190,503

Avg. volume

1.1M

P/E ratio

-25.00

ELITE PHARMS INC by Elite Pharmaceuticals, Inc. News